The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Much Larger Will The Plasma Protein Therapeutics Market Become By 2030 Compared To 2026?
The plasma protein therapeutics market size has shown significant growth in recent years. It is anticipated to expand from $34.68 billion in 2025 to $37.09 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.9%. The increase during the historical period can be ascribed to the growing incidence of primary immunodeficiency disorder, an escalating need for immunoglobulin therapies, a constrained plasma donation infrastructure, developments in protein purification technologies, and regulatory clearances for plasma-derived treatments.
The plasma protein therapeutics market size is anticipated to demonstrate robust expansion over the next few years, with projections indicating growth to $48.98 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. This expected increase during the forecast period can be attributed to the rise in recombinant albumin and coagulation factors, the proliferation of subcutaneous administration methods, escalating healthcare spending in developing markets, advancements in precision medicine technology, and an increase in public-private collaborations for plasma collection. Significant trends foreseen in this period include the evolution of personalized plasma protein therapy, an increase in recombinant protein production, wider acceptance of subcutaneous administration, growing recognition of rare blood disorders, and improved supply chain and cold chain logistics.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9213&type=smp
What Core Drivers Are Transforming The Plasma Protein Therapeutics Market?
The escalating occurrence of autoimmune conditions is anticipated to fuel expansion within the plasma protein therapeutics market moving forward. An autoimmune disorder is characterized by the body’s immune system mistakenly attacking and eliminating its own healthy cells. Therapeutic plasma exchange serves as a treatment for autoimmune diseases, which arise when the body perceives its own components as foreign, leading to the generation of proteins (known as autoantibodies) that target these misidentified body parts. For instance, in May 2023, research conducted by the University of Glasgow, a UK-based public university, involving 22 million individuals, revealed that autoimmune disorders impact approximately 10% of the UK’s populace, surpassing prior forecasts from 2022. Consequently, the rising incidence of autoimmune disorders is a key factor propelling the growth of the plasma protein therapeutics market in the future.
What Are The Major Segment Categories Within The Plasma Protein Therapeutics Market?
The plasma protein therapeutics market covered in this report is segmented –
1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products
2) By Route Of Administration: Intravenous, Subcutaneous
3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications
Subsegments:
1) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
2) By Albumin: Human Serum Albumin, Recombinant Albumin
3) By Coagulation Factor: Factor VIII, Factor IX, Prothrombin Complex Concentrates
4) By C1-Esterase Inhibitors: Human C1-Esterase Inhibitors, Recombinant C1-Esterase Inhibitors
5) By Other Products: Fibrinogen, Alpha-1 Antitrypsin, Clotting Factor Concentrates
What Trends Are Affecting The Growth Of The Plasma Protein Therapeutics Market?
Major companies operating in the plasma protein therapeutics market are focusing on developing innovative solutions, such as lyophilized plasma formulations, to meet the rising demand for portable, stable, and rapid-use blood products in emergency and pre-hospital care settings. Lyophilized plasma products are freeze-dried formulations that offer longer shelf life, easier storage, and quicker reconstitution compared to traditional frozen plasma, making them highly suitable for trauma, emergency medicine, and field environments. For instance, in October 2023, Octapharma AG, a Switzerland-based pharmaceutical company, received approval from European medical authorities for the lyophilized version of its octaplasLG product. This advanced formulation enables convenient pre-hospital transfusion, offering rapid availability, simplified handling, and improved stability for critical care situations. The product supports effective management of trauma and bleeding emergencies, demonstrating Octapharma’s commitment to advancing patient care through innovative plasma-based therapies.
Which Organizations Are Operating Within The Plasma Protein Therapeutics Market?
Major companies operating in the plasma protein therapeutics market are CSL Behring LLC, Grifols SA, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion SpA, LFB SA, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions BV, Bio Products Laboratory Ltd., Biotest AG, Taibang Biological Group Co Ltd, Octapharma Plasma Inc., Green Cross Corporation, China National Biotec Group Company Limited, Kamada Ltd., Shire PLC, Octapharma AG
Access The Complete Plasma Protein Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report
Which Region Is The Dominant Market In The Plasma Protein Therapeutics Market?
North America was the largest region in the plasma protein therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma protein therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Plasma Protein Therapeutics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=9213&type=smp
Browse Through More Reports Similar to the Global Plasma Protein Therapeutics Market 2026, By The Business Research Company
Plasma Protein Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report
Therapeutic Plasma Exchange Market Report 2026
https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report
Peptide Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model